Trial intelligence / Profile preview

NBM-DBS in Alzheimer's Disease

NCT03959124Unknown

Sponsor
Buddhist Tzu Chi General Hospital
Start
Apr 2020
Primary completion
Sep 2020
Countries
1
01

Overview

Open-label trial in Alzheimer's disease (AD) (3 arms), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: Alzheimer's Disease Assessment Scale-cognitive subscale at 1 year. Status: unknown.

02

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT03959124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03959124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call